[HTML][HTML] INSM1 expression in a subset of thoracic malignancies and small round cell tumors: rare potential pitfalls for small cell carcinoma

HK Tsai, JL Hornick, M Vivero - Modern Pathology, 2020 - Elsevier
INSM1 is a diagnostic marker for neuroendocrine tumors originating in multiple anatomic
sites. In the lung, INSM1 shows 76–97% sensitivity for neuroendocrine tumors overall. Our …

Changes in mouse thymus and spleen after return from the STS-135 mission in space

DS Gridley, XW Mao, LS Stodieck, VL Ferguson… - PloS one, 2013 - journals.plos.org
Our previous results with flight (FLT) mice showed abnormalities in thymuses and spleens
that have potential to compromise immune defense mechanisms. In this study, the organs …

[HTML][HTML] Nucleic acid aptamers as potential therapeutic and diagnostic agents for lymphoma

KT Shum, J Zhou, JJ Rossi - Journal of cancer therapy, 2013 - ncbi.nlm.nih.gov
Lymphomas are cancers that arise from white blood cells and usually present as solid
tumors. Treatment of lymphoma often involves chemotherapy, and can also include …

Tissue flow cytometry immunophenotyping in the diagnosis and classification of non‐Hodgkin's lymphomas: A retrospective evaluation of 1,792 cases

A Demurtas, A Stacchini, S Aliberti… - Cytometry Part B …, 2013 - Wiley Online Library
A retrospective analysis of 1,792 solid tissues suggestive of lymphoma, submitted over a 12‐
year period, was carried out and flow cytometry (FC) results were compared with histologic …

[HTML][HTML] CD56 positive diffuse large B-cell lymphoma: a case report and literature review

MJ Gu, JO Ha - International Journal of Clinical and Experimental …, 2013 - ncbi.nlm.nih.gov
CD56 positive B-cell lymphoma is very rare. We experienced a case of CD56 positive diffuse
large B-cell lymphoma, occurred in a young child. A 5-year-old girl complained with snoring …

CD56-positive diffuse large B-cell lymphoma/leukemia with BCL6/MYC double-hit and multiple gene mutations: an indicator of poor prognosis?

Y Liu, J Shen, M Awal Issah, T Liu… - Journal of …, 2020 - journals.sagepub.com
Diffuse large B-cell lymphoma (DLBCL) is the most common adult non-Hodgkin lymphoma
(NHL) and is highly invasive, with a poor prognosis. The main clinical treatment for DLBCL …

[HTML][HTML] CD56 expression in odontogenic cysts and tumors

Z Jaafari-Ashkavandi… - Journal of Dental …, 2014 - ncbi.nlm.nih.gov
Background and aims. Odontogenic cysts and tumors have a wide spectrum of clinical
characteristics that lead to the different management strategies. Since definite diagnosis is …

CD56-positive diffuse large B-cell lymphoma: comprehensive analysis of clinical, pathological, and molecular characteristics with literature review

G Gasljevic, L Boltezar, S Novakovic… - Radiology and …, 2023 - sciendo.com
CD56-positive diffuse large B-cell lymphoma: comprehensive analysis of clinical, pathological,
and molecular characteristics wit Page 1 Radiology and Oncology | Ljubljana | Slovenia …

Contextualizing the genes altered in bladder neoplasms in pediatric and teen patients allows identifying two main classes of biological processes involved and new …

A Porrello, R Piergentili - Current Genomics, 2016 - ingentaconnect.com
Research on bladder neoplasms in pediatric and teen patients (BNPTP) has described 21
genes, which are variously involved in this disease and are mostly responsible for …

Neural cell adhesion molecule (CD56)-positive B cell lymphoma of the urinary bladder

T Kawasaki, M Suzuki, A Sato… - Journal of Clinical …, 2016 - jcp.bmj.com
CD56, the neural cell adhesion molecule (NCAM), is a member of the immunoglobulin
superfamily and is associated with cell-to-cell adhesion and migration. 1 Among …